The recent European approval of lutetium (177Lu) oxodotreotide increases treatment options for gastroenteropancreatic neuroendocrine tumors
Author:
Affiliation:
1. Neuroendocrine Tumour Unit, Royal Free London & University College London, London, NW3 2QG, UK
Publisher
Future Medicine Ltd
Subject
Cancer Research,Endocrinology,Oncology,Endocrinology, Diabetes and Metabolism
Link
https://www.futuremedicine.com/doi/pdf/10.2217/ije-2018-0002
Reference20 articles.
1. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
2. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
3. Interventional Oncology
4. Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: Results from the large database of a multidisciplinary group clinical multicenter study
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development and Validation of Novel Z-360-Based Macromolecules for the Active Targeting of CCK2-R;Molecular Pharmaceutics;2024-07-03
2. Neutron and gamma ray shielding behavior of some low-Z materials using the n-γ reaction;Advanced Radiation Shielding Materials;2024
3. Determination of neutron moderation parameters through neutron captured gamma ray emission – A novel method;Annals of Nuclear Energy;2022-06
4. An update of new small-molecule anticancer drugs approved from 2015 to 2020;European Journal of Medicinal Chemistry;2021-08
5. Response rates in metastatic neuroendocrine tumors receiving peptide receptor radionuclide therapy and implications for future treatment strategies;Surgery;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3